Clinical Trial Update: Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction [EARLY_Phase 1]

View source ↗

Summary

A Phase EARLY_PHASE1 trial evaluating longer-term adrenal suppression with low-dose hydrocortisone to reduce androgen overproduction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperandrogenism
• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: University of Virginia | Conditions: Hyperandrogenemia, Obesity | EARLY_Phase 1 | Status: WITHDRAWN